Thrombosis and cancer

Immune checkpoint inhibitors and cancer-associated thrombosis: an overview

Immune checkpoint inhibitors (ICIs) are a type of immunotherapy that revolutionized cancer treatment and, in recent...

Patients with cancer have a high risk of recurrent venous thromboembolism (VTE) and major bleeding, which greatly...

Cancer patients face numerous challenges on their journey, and one often overlooked concern is the increased risk of...

Although thrombosis is the second cause of death in patients with cancer, after cancer itself, most of these patients...

Atrial fibrillation (AF) is common in patients with cancer, and up to one in every four persons with AF has comorbid...

The Problem The estimated incidence of cancer-associated thrombosis (CAT) is increasing over time and ranges from 1.6%...

Venous thromboembolism (VTE) is the second cause of death in people with cancer, after cancer itself. Cancer and VTE...

Cancer patients are often prescribed more than one drug and the need to elucidate potential harmful interactions...

During the ICTHIC webinar, “Long-term treatment & DDI implications in the management of CAT,” Dr. Tzu-Fei Wang...

Venous thromboembolism (VTE) is a well-recognized complication in patients with cancer, with an increase in risk by a...